03/05/2021at 13:54

Biomarin gets ready for launch in second half-year of 2021

Biomarin's revenue retreated in Q1 but the company will receive news on several applications in the following months.

BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

June will be a significant month for Biomarin on several accounts.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

Access all locked articles
Receive our daily newsletters
Access our app

Get full access for you and your coworkers

Start a free company trial today

Bavarian Nordic on new capital raising round: Covid-19 was the decisive factor
For subscribers
Bavarian Nordic still hopes to find financing for Covid-19 vaccine
For subscribers
Biomarin's previously rejected hemophilia drug gets special status at the FDA
For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Front page now

Michael Løvbjerg, CEO and co-founder of Lizn | Photo: Lizn / Pr

Hearing health

New hearing company 14 years in the making – "We expect to rise to the top"

Three hearing aid industry veterans have in secret founded a company, Lizn, while refining over many years a hearing device that is now ready to be launched.

For subscribers

Regulation

Another UK authority looking into Novo Nordisk's marketing violation

For subscribers

Pharma & biotech

Ascendis Pharma initiates long-term study of Skytrofa

For subscribers

Pharma & biotech

Roche and Eli Lilly to collaborate on early Alzheimer's detection test

For subscribers

Britt Meelby Jensen, CEO of Ambu | Foto: Ambu/pr

Medtech

Ambu CEO: Technology, scalability and partnerships will ensure growth

For subscribers

Medtech

Nordea finds new Ambu targets encouraging and trustworthy

New hearing company 14 years in the making – "We expect to rise to the top"

Three hearing aid industry veterans have in secret founded a company, Lizn, while refining over many years a hearing device that is now ready to be launched.

For subscribers

Leo Pharma has kicked up a dust over Jörg Möller's future at the company | Foto: Magnus Møller

Pharma & biotech

Cryptic message about future of Leo Pharma's R&D chief left unexplained

Jörg Möller has accepted a – temporary – new role at Leo Pharma, but the company declines to explain what that means for the future.

For subscribers

Regulation

Another UK authority looking into Novo Nordisk's marketing violation

The Medicines and Healthcare products Regulatory Agency will investigate ”whether regulatory action is also appropriate” after another UK authority took action against the Danish drugmaker.

For subscribers